161 related articles for article (PubMed ID: 25545367)
1. Cdk1-mediated phosphorylation of human ATF7 at Thr-51 and Thr-53 promotes cell-cycle progression into M phase.
Hasegawa H; Ishibashi K; Kubota S; Yamaguchi C; Yuki R; Nakajo H; Eckner R; Yamaguchi N; Yokoyama KK; Yamaguchi N
PLoS One; 2014; 9(12):e116048. PubMed ID: 25545367
[TBL] [Abstract][Full Text] [Related]
2. A cytoplasmic negative regulator isoform of ATF7 impairs ATF7 and ATF2 phosphorylation and transcriptional activity.
Diring J; Camuzeaux B; Donzeau M; Vigneron M; Rosa-Calatrava M; Kedinger C; Chatton B
PLoS One; 2011; 6(8):e23351. PubMed ID: 21858082
[TBL] [Abstract][Full Text] [Related]
3. ATF7 is stabilized during mitosis in a CDK1-dependent manner and contributes to cyclin D1 expression.
Schaeffer E; Vigneron M; Sibler AP; Oulad-Abdelghani M; Chatton B; Donzeau M
Cell Cycle; 2015; 14(16):2655-66. PubMed ID: 26101806
[TBL] [Abstract][Full Text] [Related]
4. ATF2 and ATF7 Are Critical Mediators of Intestinal Epithelial Repair.
Meijer BJ; Giugliano FP; Baan B; van der Meer JHM; Meisner S; van Roest M; Koelink PJ; de Boer RJ; Jones N; Breitwieser W; van der Wel NN; Wildenberg ME; van den Brink GR; Heijmans J; Muncan V
Cell Mol Gastroenterol Hepatol; 2020; 10(1):23-42. PubMed ID: 31958521
[TBL] [Abstract][Full Text] [Related]
5. p38beta2-mediated phosphorylation and sumoylation of ATF7 are mutually exclusive.
Camuzeaux B; Diring J; Hamard PJ; Oulad-Abdelghani M; Donzeau M; Vigneron M; Kedinger C; Chatton B
J Mol Biol; 2008 Dec; 384(4):980-91. PubMed ID: 18950637
[TBL] [Abstract][Full Text] [Related]
6. Ribosomal protein S3 is phosphorylated by Cdk1/cdc2 during G2/M phase.
Yoon IS; Chung JH; Hahm SH; Park MJ; Lee YR; Ko SI; Kang LW; Kim TS; Kim J; Han YS
BMB Rep; 2011 Aug; 44(8):529-34. PubMed ID: 21871177
[TBL] [Abstract][Full Text] [Related]
7. Citrate-Induced p85α⁻PTEN Complex Formation Causes G
Hung KC; Wang SG; Lin ML; Chen SS
Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035650
[TBL] [Abstract][Full Text] [Related]
8. Complex formation of Plk1 and INCENP required for metaphase-anaphase transition.
Goto H; Kiyono T; Tomono Y; Kawajiri A; Urano T; Furukawa K; Nigg EA; Inagaki M
Nat Cell Biol; 2006 Feb; 8(2):180-7. PubMed ID: 16378098
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of CBF/NF-Y mediated transcription activation arrests cells at G2/M phase and suppresses expression of genes activated at G2/M phase of the cell cycle.
Hu Q; Lu JF; Luo R; Sen S; Maity SN
Nucleic Acids Res; 2006; 34(21):6272-85. PubMed ID: 17098936
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cdk1 by alsterpaullone and thioflavopiridol correlates with increased transit time from mid G2 through prophase.
Soni DV; Jacobberger JW
Cell Cycle; 2004 Mar; 3(3):349-57. PubMed ID: 14726692
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of Rho GTPases with Clostridium difficile toxin B impairs centrosomal activation of Aurora-A in G2/M transition of HeLa cells.
Ando Y; Yasuda S; Oceguera-Yanez F; Narumiya S
Mol Biol Cell; 2007 Oct; 18(10):3752-63. PubMed ID: 17634283
[TBL] [Abstract][Full Text] [Related]
12. KCTD12 promotes tumorigenesis by facilitating CDC25B/CDK1/Aurora A-dependent G2/M transition.
Zhong Y; Yang J; Xu WW; Wang Y; Zheng CC; Li B; He QY
Oncogene; 2017 Nov; 36(44):6177-6189. PubMed ID: 28869606
[TBL] [Abstract][Full Text] [Related]
13. Cyclin B1-Cdk1 activation continues after centrosome separation to control mitotic progression.
Lindqvist A; van Zon W; Karlsson Rosenthal C; Wolthuis RM
PLoS Biol; 2007 May; 5(5):e123. PubMed ID: 17472438
[TBL] [Abstract][Full Text] [Related]
14. EphA2 phosphorylation at Ser897 by the Cdk1/MEK/ERK/RSK pathway regulates M-phase progression via maintenance of cortical rigidity.
Kaibori Y; Saito Y; Nakayama Y
FASEB J; 2019 Apr; 33(4):5334-5349. PubMed ID: 30668924
[TBL] [Abstract][Full Text] [Related]
15. Sensitisation of c-MYC-induced B-lymphoma cells to apoptosis by ATF2.
Walczynski J; Lyons S; Jones N; Breitwieser W
Oncogene; 2014 Feb; 33(8):1027-36. PubMed ID: 23416976
[TBL] [Abstract][Full Text] [Related]
16. Role for non-proteolytic control of M-phase-promoting factor activity at M-phase exit.
D'Angiolella V; Palazzo L; Santarpia C; Costanzo V; Grieco D
PLoS One; 2007 Feb; 2(2):e247. PubMed ID: 17327911
[TBL] [Abstract][Full Text] [Related]
17. Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells.
Hirota T; Kunitoku N; Sasayama T; Marumoto T; Zhang D; Nitta M; Hatakeyama K; Saya H
Cell; 2003 Sep; 114(5):585-98. PubMed ID: 13678582
[TBL] [Abstract][Full Text] [Related]
18. Roles of aurora-A kinase in mitotic entry and G2 checkpoint in mammalian cells.
Marumoto T; Hirota T; Morisaki T; Kunitoku N; Zhang D; Ichikawa Y; Sasayama T; Kuninaka S; Mimori T; Tamaki N; Kimura M; Okano Y; Saya H
Genes Cells; 2002 Nov; 7(11):1173-82. PubMed ID: 12390251
[TBL] [Abstract][Full Text] [Related]
19. Suppression of Vimentin Phosphorylation by the Avian Reovirus p17 through Inhibition of CDK1 and Plk1 Impacting the G2/M Phase of the Cell Cycle.
Chiu HC; Huang WR; Liao TL; Wu HY; Munir M; Shih WL; Liu HJ
PLoS One; 2016; 11(9):e0162356. PubMed ID: 27603133
[TBL] [Abstract][Full Text] [Related]
20. ATF7-dependent epigenetic changes induced by high temperature during early porcine embryonic development.
Sun MH; Jiang WJ; Li XH; Lee SH; Heo G; Zhou D; Choi JS; Kim KS; Lv W; Cui XS
Cell Prolif; 2023 Feb; 56(2):e13352. PubMed ID: 36254813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
